Literature DB >> 1939959

Clinical and pathologic manifestations of pulmonary vascular disease in the toxic oil syndrome.

M A Gomez-Sanchez1, C Saenz de la Calzada, C Gomez-Pajuelo, F J Martinez-Tello, M J Mestre de Juan, T N James.   

Abstract

The toxic oil syndrome in Spain affected greater than 20,000 people. In the initial stages, it was characterized by a respiratory distress syndrome with myalgias and eosinophilia. Pulmonary hypertension developed in 20% of the patients and in many, it has spontaneously regressed. Nevertheless, in a small subgroup, it has progressed to a malignant course of cor pulmonale, leading rapidly to death. Clinical and pathologic features of 40 patients with severe pulmonary hypertension due to the toxic oil syndrome are presented (32 female and 8 male patients; mean age 26 +/- 13 years). The study began in June 1981, which was near the onset of the toxic oil epidemic, and ended in December 1987, greater than 6 years later. The pulmonary hypertension is clinically and pathologically indistinguishable from primary pulmonary hypertension. Direct endothelial injury by the toxic agent is proposed as the initial trigger of this type of pulmonary hypertension, but an interaction between the toxic agent and specific individual susceptibility is probably required in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939959     DOI: 10.1016/0735-1097(91)90688-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  4 in total

Review 1.  Primary pulmonary hypertension: the pressure rises for a gene.

Authors:  J R Thomson; R C Trembath
Journal:  J Clin Pathol       Date:  2000-12       Impact factor: 3.411

2.  BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension.

Authors:  R D Machado; M W Pauciulo; J R Thomson; K B Lane; N V Morgan; L Wheeler; J A Phillips; J Newman; D Williams; N Galiè; A Manes; K McNeil; M Yacoub; G Mikhail; P Rogers; P Corris; M Humbert; D Donnai; G Martensson; L Tranebjaerg; J E Loyd; R C Trembath; W C Nichols
Journal:  Am J Hum Genet       Date:  2000-12-12       Impact factor: 11.025

3.  Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family.

Authors:  J R Thomson; R D Machado; M W Pauciulo; N V Morgan; M Humbert; G C Elliott; K Ward; M Yacoub; G Mikhail; P Rogers; J Newman; L Wheeler; T Higenbottam; J S Gibbs; J Egan; A Crozier; A Peacock; R Allcock; P Corris; J E Loyd; R C Trembath; W C Nichols
Journal:  J Med Genet       Date:  2000-10       Impact factor: 6.318

4.  2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension.

Authors:  Chih-Hsin Hsu; Wan-Jing Ho; Wei-Chun Huang; Yu-Wei Chiu; Tsu-Shiu Hsu; Ping-Hung Kuo; Hsao-Hsun Hsu; Jia-Kan Chang; Chin-Chang Cheng; Chao-Lun Lai; Kae-Woei Liang; Shoa-Lin Lin; Hsao-Hsun Sung; Wei-Chuan Tsai; Ken-Pen Weng; Kai-Sheng Hsieh; Wei-Hsian Yin; Shing-Jong Lin; Kuo-Yang Wang
Journal:  Acta Cardiol Sin       Date:  2014-09       Impact factor: 2.672

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.